Mereo BioPharma Group Plc (MREO)
0.2764
+0.01
(+3.60%)
USD |
NASDAQ |
Sep 01, 16:00
0.2711
-0.01
(-1.92%)
After-Hours: 19:41
Mereo BioPharma Group Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2025 | 0.00 |
| December 31, 2024 | 5.722M |
| September 30, 2024 | 5.945M |
| June 30, 2024 | 5.483M |
| March 31, 2024 | 5.357M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | 0.00 |
| NuCana Plc | 0.892M |
| BioNTech SE | 349.05M |
| Silence Therapeutics Plc | 0.009M |
| Autolus Therapeutics Plc | 362.02M |